| C - Cardiovascular System | | |
|
| C10 - Lipid Modifying Agents | | | The DDDs are based on the treatment of hypercholesterolemia.
|
|
| C10A - Lipid Modifying Agents, plain | Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.
|
|
| C10AA - Hmg Coa Reductase Inhibitors | This group comprises agents which act as competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase).
Atorvastatin in combination with amlodipine is classified in C10BX03.
|
|
| C10AA07 - Rosuvastatin | | Dose | Route of administration | Note |
|---|
| | O | |
|
|
